With over 20 years of experience working in the Pharmaceutical industry, focusing primarily on regulated, clinical and preclinical bioanalytical studies for small molecules and their metabolites, and biomarkers. My expertise includes:
My mission is to provide fast, efficient and time-saving bioanalytical Services to Pharmaceutical and other related organisations e.g. Contract Research Organisations (CROs), Academia and start-up organisations during both drug discovery and development phases.
I can support your team in-house or remotely, for a fixed period of time or consult on a particular section of a project.
Whatever your Bioanalytical requirements, I can be flexible to your organisation's needs.
When undertaking method development, validation, documentation and data review of small molecule xenobiotic and endogenous biomarkers for preclinical and clinical project support, I understand how challenging it can be.
The determination of drug concentration quantitatively and/or qualitatively in various matrices has different requirements or ways to approach the analysis. This is where Wright Bioanalytical Consultancy Services can support you.
I am happy to support you with one, or any combination, of the below services. If your requirements are outside of these task areas, please don't hesitate to contact me to see how I can support you.
Method Development is a key stage to providing bioanalytical support for the quantification of small molecule xenobiotic and endogenous biomarkers for supporting preclinical and clinical studies.
I can provide a full in-house design service or support your existing team by providing an experienced, and unbiased, set of eyes to troubleshoot and propose alternative approaches or ideas that could be more robust, effective and less time-consuming.
The development of a full step-by-step validation plan. This will ensure the method is reliable and robust, provide quality data, and achieve all industry-regulated standards.
Providing fast, effective and critical data review of method validation and sample analysis results in line with in-house SOPs and regulatory guidelines.
Delivering a fast, efficient, constructive and unbiased review of your validation and sample analysis report ensuring it is comprehensive and accurate.
Reviewing the Bioanalytical aspect of preclinical and clinical study protocols to ensure sample collection, storage and analysis plans are in accordance with the validated method and stakeholder expectations.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.